Five-year follow-up of the ABSORB bioresorbable everolimus-eluting vascular scaffold system: multimodality imaging assessment Garcia-Garcia H, Schultz C, Duckers H, Regar E, Ligthart J, Serruys P, van Geuns R February 22, 2013 | 10.4244/EIJV8I10A187
Plaque sealing and passivation with a mechanical self-expanding low outward force nitinol vShield device for the treatment of IVUS and OCT-derived thin cap fibroatheromas (TCFAs) in native coronary arteries: report of the pilot study vShield Evaluated at Cardiac hospital in Rotterdam for Investigation and Treatment of TCFA (SECRITT) Wykrzykowska J, Diletti R, Gutiérrez-Chico J-L, van Geuns R, van der Giessen WJ, Ramcharitar S, Duckers H, Schultz C, de Feyter P, van der Ent M, Regar E, de Jaegere P, Garcia-Garcia H, Pawar R, Gonzalo N, Ligthart J, de Schepper J, van den Berg N, Milewski K, Granada J, Serruys P December 28, 2012 | 10.4244/EIJV8I8A144
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3) Simsek C, Garcia-Garcia H, van Geuns R, Magro M, Girasis C, Van Mieghem N, Lenzen M, de Boer S, Regar E, van der Giessen WJ, Raichlen J, Duckers H, Zijlstra F, van der Steen A, Boersma E, Serruys P June 27, 2012 | 10.4244/EIJV8I2A37
Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first Gutiérrez-Chico J-L, van Geuns R, Koch K, Koolen J, Duckers H, Regar E, Serruys P October 28, 2011 | 10.4244/EIJV7I6A114
Moxy® drug-coated balloon: a novel device for the treatment of coronary and peripheral vascular disease Gutiérrez-Chico J-L, Regar E, van Geuns R, Garg S, Schultz C, Van Mieghem N, Duckers H, Serruys P June 30, 2011 | 10.4244/EIJV7I2A44
Intravascular ultrasound radiofrequency analysis after optimal coronary stenting with initial quantitative coronary angiography guidance: an ATHEROREMO sub-study Sarno G, Garg S, Gomez-Lara J, Garcia-Garcia H, Ligthart J, Bruining N, Onuma Y, Witberg K, van Geuns R, de Boer S, Wykrzykowska J, Schultz C, Duckers H, Regar E, de Jaegere P, de Feyter P, Van Es G-A, Boersma E, van der Giessen WJ, Serruys P March 21, 2011
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial Duckers H, Houtgraaf J, Hehrlein C, Schofer J, Waltenberger J, Gershlick A, Bartunek J, Nienaber C, Naber C, Macaya C, Peters N, Smits P, Siminiak T, van Mieghem W, Legrand V, Serruys P February 21, 2011
Endothelial Progenitor Cell (EPC) capture to aid vascular repair following coronary stenting: a new frontier in stent technology? Houtgraaf J, Duckers H August 20, 2008
Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: final results of the Healing II trial using an endothelial progenitor cell capturing stent (Genous R stent)™ Duckers H, Soullié T, den Heijer P, Rensing B, de Winter R, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys P November 20, 2007
Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: evaluation of an endothelial progenitor cell capturing stent Duckers H, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys P May 22, 2007
Adipose derived stem cells: new kids on the block Meliga E, Duckers H, van Geuns R, Regar E, de Jaegere P, van der Giessen WJ, Serruys P May 22, 2007
Clinical experience with autologous myoblast transplantation Meliga E, Duckers H, Spencer R, Kalmucki P, Serruys P, Siminiak T May 22, 2007
Rationale and interim analysis data from the SEISMIC study Meliga E, Duckers H, Spencer R, Serruys P May 22, 2007
The Bedside Celution™ system for isolation of adipose derived regenerative cells Duckers H, Pinkernell K, Milstein AM, Hedrick MH November 20, 2006
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019